Home
Details for: Discrepant susceptibility to gentamicin despite amikacin resistance in Klebsiella pneumoniae by VITEK 2 represents false susceptibility associated with the armA 16S rRNA methylase gene.

Normal view MARC view ISBD view

Discrepant susceptibility to gentamicin despite amikacin resistance in Klebsiella pneumoniae by VITEK 2 represents false susceptibility associated with the armA 16S rRNA methylase gene. [electronic resource]

By:

Ko, Jae-Hoon

Contributor(s):

Baek, Jin Yang
Peck, Kyong Ran
Cho, Sun Young
Ha, Young Eun
Kim, So Hyun
Huh, Hee Jae
Lee, Nam Yong
Kang, Cheol-In
Chung, Doo Ryeon
Song, Jae-Hoon

Producer: 20171018Description: 1448-1450 p. digitalISSN:

1473-5644

Subject(s):

Amikacin -- pharmacology
Anti-Bacterial Agents -- pharmacology
Drug Resistance, Multiple, Bacterial
Gene Expression Regulation, Bacterial
Gene Expression Regulation, Enzymologic
Gentamicins -- pharmacology
Klebsiella pneumoniae -- drug effects
Methyltransferases -- genetics
Microbial Sensitivity Tests -- methods

Online resources:

Available from publisher's website

In: Journal of medical microbiology vol. 66

Tags from this library: No tags from this library for this title. Log in to add tags.

Star ratings

Cancel rating. Average rating: 0.0 (0 votes)

Holdings ( 0 )
Title notes ( 1 )
Comments ( 0 )

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

Browse results Close

Back to results

1 A review of health related quality of life in systemic lupus erythematosus.
by McElhone, K
2 GMDP and psoriasis.
by Bhushan, M
3 Patient perspective of systemic lupus erythematosus in relation to health-related quality of life concepts: a qualitative study.
by McElhone, K
4 Oral liarozole in the treatment of palmoplantar pustular psoriasis: a randomized, double-blind, placebo-controlled study.
by Bhushan, M
5 The effects of low-dose testosterone treatment on lipid metabolism, clotting factors and ultrasonographic ovarian morphology in women.
by Buckler, H M
6 Successful treatment of psoriasis improves psoriasis-specific but not more general aspects of patients' well-being.
by Fortune, D G
7 Lupus-specific health outcome measure for US patients: the LupusQoL-US version.
by Jolly, M
8 The British Association of Dermatologists' Biologic Interventions Register (BADBIR): design, methodology and objectives.
by Burden, A D
9 Comparative effectiveness of biological therapies on improvements in quality of life in patients with psoriasis.
by Iskandar, I Y K
10 Identification of factors that may influence the selection of first-line biological therapy for people with psoriasis: a prospective, multicentre cohort study.
by Davison, N J
11 Biaryl diacid inhibitors of human s-PLA2 with anti-inflammatory activity.
by Springer, D M
12 Is the Disease-Specific Lupusqol Sensitive To Changes of Disease Activity In Systemic Lupus Erythematosus Patients After Treatment of A Flare?
by McElhone, K
13 Patterns of biologic therapy use in the management of psoriasis: cohort study from the British Association of Dermatologists Biologic Interventions Register (BADBIR).
by Iskandar, I Y K
14 A standardization approach to compare treatment safety and effectiveness outcomes between clinical trials and real-world populations in psoriasis.
by Yiu, Z Z N
15 Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the U.K. and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR).
by Yiu, Z Z N
16 Demographics and disease characteristics of patients with psoriasis enrolled in the British Association of Dermatologists Biologic Interventions Register.
by Iskandar, I Y K
17 Persistence and effectiveness of nonbiologic systemic therapies for moderate-to-severe psoriasis in adults: a systematic review.
by Mason, K J

Discrepant susceptibility to gentamicin despite amikacin resistance in Klebsiella pneumoniae by VITEK 2 represents false susceptibility associated with the armA 16S rRNA methylase gene.

APA

Ko J., Baek J. Y., Peck K. R., Cho S. Y., Ha Y. E., Kim S. H., Huh H. J., Lee N. Y., Kang C., Chung D. R. & Song J. (20171018). Discrepant susceptibility to gentamicin despite amikacin resistance in Klebsiella pneumoniae by VITEK 2 represents false susceptibility associated with the armA 16S rRNA methylase gene. : Journal of medical microbiology.

Chicago

Ko Jae-Hoon, Baek Jin Yang, Peck Kyong Ran, Cho Sun Young, Ha Young Eun, Kim So Hyun, Huh Hee Jae, Lee Nam Yong, Kang Cheol-In, Chung Doo Ryeon and Song Jae-Hoon. 20171018. Discrepant susceptibility to gentamicin despite amikacin resistance in Klebsiella pneumoniae by VITEK 2 represents false susceptibility associated with the armA 16S rRNA methylase gene. : Journal of medical microbiology.

Harvard

Ko J., Baek J. Y., Peck K. R., Cho S. Y., Ha Y. E., Kim S. H., Huh H. J., Lee N. Y., Kang C., Chung D. R. and Song J. (20171018). Discrepant susceptibility to gentamicin despite amikacin resistance in Klebsiella pneumoniae by VITEK 2 represents false susceptibility associated with the armA 16S rRNA methylase gene. : Journal of medical microbiology.

MLA

Ko Jae-Hoon, Baek Jin Yang, Peck Kyong Ran, Cho Sun Young, Ha Young Eun, Kim So Hyun, Huh Hee Jae, Lee Nam Yong, Kang Cheol-In, Chung Doo Ryeon and Song Jae-Hoon. Discrepant susceptibility to gentamicin despite amikacin resistance in Klebsiella pneumoniae by VITEK 2 represents false susceptibility associated with the armA 16S rRNA methylase gene. : Journal of medical microbiology. 20171018.

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Simple DC-RDF

OAI-DC

SRW-DC